www.alk.net
  • Patients
    • What is allergy
      • House dust mite allergy
      •  
      • Pollen allergy
      •  
      • Living with allergy
      •  
      • Socio-economic impact
      •  
    •  
    • What is allergic asthma
    •  
    • How is allergy diagnosed
    •  
    • Treating allergy
    •  
  •  
  • Healthcare Professionals
    • Treating allergy and asthma
    •  
    • Products
    •  
    • Adverse reactions
    •  
    • Initiation of treatment
    •  
    • Clinical trials
    •  
  •  
  • R&D
    • R&D pipeline
    •  
    • Understanding immunotherapy
    •  
    • Research
    •  
    • Congress activities
    •  
    • Clinical data sharing
    •  
  •  
  • Careers
    • Working at ALK
    •  
    • Vacant positions
    •  
  •  
  • Investors
    • Overview
    •  
    • Financial reporting
      • Risk management
      •  
      • Reporting standards
      •  
      • Auditors
      •  
    •  
    • Governance
      • IR policy
      •  
      • Management
      •  
      • Board of directors
      •  
      • Annual general meeting
      •  
      • Annual general meeting (DK)
      •  
    •  
    • News & Events
      • Company Releases
      •  
      • Company releases (DK)
      •  
      • Webcasts & presentations
      •  
      • Investor calendar
      •  
    •  
    • The Share
      • Dividend history
      •  
      • Analyst coverage
      •  
      • Analyst estimates
      •  
      • Shareholder information
      •  
      • Authorizations
      •  
      • ADR Programme
      •  
    •  
    • Contact IR
    •  
    • Management
    •  
    • Board of directors
    •  
    • AGM
    •  
    • AGM (DK)
    •  
    • Nyheder
    •  
    • Nyheder (EN)
    •  
  •  
  • Media
  •  
  • About
    • ALK at a glance
    •  
    • CSR
    •  
    • Production
    •  
    • Global presence
    •  
    • Organisation
    •  
    • History
    •  
    • Values
    •  
    • Owners
    •  
  •  
  • Select country
  •  
Search

Company releases

Links: 
Company Releases
Company releases (DK)
Webcasts & presentations
Investor calendar
DateTitle
17-12-2020 12:32 EST ALK – Financial calendar for the 2021 financial year
16-11-2020 11:07 EST Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
11-11-2020 1:32 EST Nine-month interim report (Q3) 2020
6-11-2020 3:20 EST Two new members of ALK’s Board of Directors
5-11-2020 8:00 EST Release date of nine-month interim report (Q3) 2020 for ALK and audio cast
5-11-2020 2:32 EST ALK updates its full-year financial outlook
12-8-2020 1:31 EDT Six-month interim report (Q2) 2020
5-8-2020 3:45 EDT Release date of six-month interim report (Q2) 2020 for ALK and audio cast
20-5-2020 11:05 EDT Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
11-5-2020 10:19 EDT Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
6-5-2020 1:00 EDT Three-month interim report (Q1) 2020
28-4-2020 3:00 EDT Release date of three-month interim report (Q1) 2020 for ALK and audio cast
19-3-2020 13:17 EDT Grant of share options and performance shares to members of the Board of Management and key employees
11-3-2020 12:26 EDT Annual General Meeting in ALK-Abelló A/S held on 11 March 2020
9-3-2020 11:39 EDT ALK-Abelló A/S' Annual General Meeting 2020
3-3-2020 10:24 EST Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
13-2-2020 8:00 EST Annual General Meeting in ALK-Abelló A/S on 11 March 2020
5-2-2020 1:00 EST ALK releases its 2019 annual report
 
  • Email Alerts

    Email Alerts

  • Downloads

    Downloads

  • RSS

    RSS

  • Print

    Print

  • Share

    Share

  • English

    English

  • Search

    Search




Select Country Menu

  • Change Country

Quick Links

  • Contact us
  • News
  • Media
  • Vacant jobs
  • Products

ALK Footer Copyright Text

ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Legal disclaimer © ALK ∙ All rights reserved